401k Plan data: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN plan

NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 401k Plan overview

Plan Name	NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN
Plan identification number	001

NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Age/Service Weighted or new comparability or similar plan - Age/Service Weighted Plan: Allocations are based on age, service, or age and service. New comparability or similar plan: Allocations are based on participant classifications and a classification(s) consists entirely or predominantly of highly compensated employees; or the plan provides an additional allocation rate on compensation above a specified threshold, and the theshold or additional rate exceeds the maximum threshold or rate allowed under the permitted disparity rules of section 401(l).
Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Participant-directed brokerage accounts provided as an investment option under the plan.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

NEW YORK ONCOLOGY HEMATOLOGY P.C. has sponsored the creation of one or more 401k plans.

Company Name: NEW YORK ONCOLOGY HEMATOLOGY P.C.

Employer identification number (EIN): 141799724

NAIC Classification: 621111
NAIC Description: Offices of Physicians (except Mental Health Specialists)

Additional information about NEW YORK ONCOLOGY HEMATOLOGY P.C.

Jurisdiction of Incorporation: New York Department of State

Incorporation Date: 1997-11-07

Company Identification Number: 2197278

Legal Registered Office Address: 400 PATROON CREEK BLVD
STE 1
ALBANY
United States of America (USA)
12206

More information about NEW YORK ONCOLOGY HEMATOLOGY P.C.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2016-01-01 IRA ZACKON IRA ZACKON 2017-06-21
001 2015-01-01 IRA ZACKON IRA ZACKON 2016-10-10
001 2014-01-01 NINI WU NINI WU 2015-10-12
001 2013-01-01 NINI WU NINI WU 2014-10-09
001 2012-01-01 NINI WU 2013-10-14
001 2012-01-01 NINI WU
001 2011-01-01 NINI WU
001 2010-01-01 NINI WU
001 2009-01-01 NINI WU

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
001	2016-01-01	IRA ZACKON	IRA ZACKON	2017-06-21
001	2015-01-01	IRA ZACKON	IRA ZACKON	2016-10-10
001	2014-01-01	NINI WU	NINI WU	2015-10-12
001	2013-01-01	NINI WU	NINI WU	2014-10-09
001	2012-01-01		NINI WU	2013-10-14
001	2012-01-01	NINI WU
001	2011-01-01	NINI WU
001	2010-01-01	NINI WU
001	2009-01-01	NINI WU

Plan Statistics for NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN

401k plan membership statisitcs for NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN

Measure Date Value
2016: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 255
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 0
Total of all active and inactive participants 2016-01-01 0
Total participants 2016-01-01 0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 245
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 181
Number of retired or separated participants receiving benefits 2015-01-01 2
Number of other retired or separated participants entitled to future benefits 2015-01-01 71
Total of all active and inactive participants 2015-01-01 254
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 1
Total participants 2015-01-01 255
Number of participants with account balances 2015-01-01 239
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 3
2014: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 245
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 181
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 63
Total of all active and inactive participants 2014-01-01 244
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 1
Total participants 2014-01-01 245
Number of participants with account balances 2014-01-01 236
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 5
2013: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 242
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 180
Number of retired or separated participants receiving benefits 2013-01-01 2
Number of other retired or separated participants entitled to future benefits 2013-01-01 62
Total of all active and inactive participants 2013-01-01 244
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 1
Total participants 2013-01-01 245
Number of participants with account balances 2013-01-01 232
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 4
2012: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 252
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 185
Number of retired or separated participants receiving benefits 2012-01-01 3
Number of other retired or separated participants entitled to future benefits 2012-01-01 53
Total of all active and inactive participants 2012-01-01 241
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 1
Total participants 2012-01-01 242
Number of participants with account balances 2012-01-01 230
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 8
2011: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 265
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 195
Number of retired or separated participants receiving benefits 2011-01-01 1
Number of other retired or separated participants entitled to future benefits 2011-01-01 55
Total of all active and inactive participants 2011-01-01 251
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 1
Total participants 2011-01-01 252
Number of participants with account balances 2011-01-01 245
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 5
2010: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2010 401k membership
Total participants, beginning-of-year 2010-01-01 277
Total number of active participants reported on line 7a of the Form 5500 2010-01-01 199
Number of retired or separated participants receiving benefits 2010-01-01 0
Number of other retired or separated participants entitled to future benefits 2010-01-01 65
Total of all active and inactive participants 2010-01-01 264
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2010-01-01 1
Total participants 2010-01-01 265
Number of participants with account balances 2010-01-01 256
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2010-01-01 7
2009: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 344
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 216
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 60
Total of all active and inactive participants 2009-01-01 276
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 1
Total participants 2009-01-01 277
Number of participants with account balances 2009-01-01 262
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 7

Measure	Date	Value
2016: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	255
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	0
Total of all active and inactive participants	2016-01-01	0
Total participants	2016-01-01	0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	245
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	181
Number of retired or separated participants receiving benefits	2015-01-01	2
Number of other retired or separated participants entitled to future benefits	2015-01-01	71
Total of all active and inactive participants	2015-01-01	254
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	1
Total participants	2015-01-01	255
Number of participants with account balances	2015-01-01	239
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	3
2014: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	245
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	181
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	63
Total of all active and inactive participants	2014-01-01	244
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	1
Total participants	2014-01-01	245
Number of participants with account balances	2014-01-01	236
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	5
2013: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	242
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	180
Number of retired or separated participants receiving benefits	2013-01-01	2
Number of other retired or separated participants entitled to future benefits	2013-01-01	62
Total of all active and inactive participants	2013-01-01	244
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	1
Total participants	2013-01-01	245
Number of participants with account balances	2013-01-01	232
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	4
2012: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	252
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	185
Number of retired or separated participants receiving benefits	2012-01-01	3
Number of other retired or separated participants entitled to future benefits	2012-01-01	53
Total of all active and inactive participants	2012-01-01	241
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	1
Total participants	2012-01-01	242
Number of participants with account balances	2012-01-01	230
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	8
2011: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	265
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	195
Number of retired or separated participants receiving benefits	2011-01-01	1
Number of other retired or separated participants entitled to future benefits	2011-01-01	55
Total of all active and inactive participants	2011-01-01	251
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	1
Total participants	2011-01-01	252
Number of participants with account balances	2011-01-01	245
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	5
2010: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2010 401k membership
Total participants, beginning-of-year	2010-01-01	277
Total number of active participants reported on line 7a of the Form 5500	2010-01-01	199
Number of retired or separated participants receiving benefits	2010-01-01	0
Number of other retired or separated participants entitled to future benefits	2010-01-01	65
Total of all active and inactive participants	2010-01-01	264
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2010-01-01	1
Total participants	2010-01-01	265
Number of participants with account balances	2010-01-01	256
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2010-01-01	7
2009: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	344
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	216
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	60
Total of all active and inactive participants	2009-01-01	276
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	1
Total participants	2009-01-01	277
Number of participants with account balances	2009-01-01	262
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	7

Financial Data on NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN

Measure	Date	Value
2016 : NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2016 401k financial data
Unrealized appreciation/depreciation of real estate assets	2016-09-15	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2016-09-15	$0
Total unrealized appreciation/depreciation of assets	2016-09-15	$0
Total transfer of assets to this plan	2016-09-15	$0
Total transfer of assets from this plan	2016-09-15	$26,123,861
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-09-15	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-09-15	$0
Expenses. Interest paid	2016-09-15	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2016-09-15	$0
Total income from all sources (including contributions)	2016-09-15	$2,159,895
Total loss/gain on sale of assets	2016-09-15	$0
Total of all expenses incurred	2016-09-15	$5,025,645
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-09-15	$4,986,037
Expenses. Certain deemed distributions of participant loans	2016-09-15	$0
Value of total corrective distributions	2016-09-15	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-09-15	$1,039,656
Value of total assets at end of year	2016-09-15	$0
Value of total assets at beginning of year	2016-09-15	$28,989,611
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-09-15	$39,608
Total income from rents	2016-09-15	$0
Total interest from all sources	2016-09-15	$6,829
Total dividends received (eg from common stock, registered investment company shares)	2016-09-15	$99,864
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-09-15	Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2016-09-15	$0
Total dividends received from registered investment company shares (eg mutual funds)	2016-09-15	$99,864
Assets. Real estate other than employer real property at end of year	2016-09-15	$0
Assets. Real estate other than employer real property at beginning of year	2016-09-15	$0
Administrative expenses professional fees incurred	2016-09-15	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2016-09-15	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2016-09-15	$0
Was this plan covered by a fidelity bond	2016-09-15	Yes
Value of fidelity bond cover	2016-09-15	$500,000
If this is an individual account plan, was there a blackout period	2016-09-15	No
Were there any nonexempt tranactions with any party-in-interest	2016-09-15	No
Contributions received from participants	2016-09-15	$1,010,273
Participant contributions at end of year	2016-09-15	$0
Participant contributions at beginning of year	2016-09-15	$200,975
Participant contributions at end of year	2016-09-15	$0
Participant contributions at beginning of year	2016-09-15	$42,306
Assets. Other investments not covered elsewhere at end of year	2016-09-15	$0
Assets. Other investments not covered elsewhere at beginning of year	2016-09-15	$1,019,698
Income. Received or receivable in cash from other sources (including rollovers)	2016-09-15	$29,383
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2016-09-15	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2016-09-15	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2016-09-15	$0
Assets. Loans (other than to participants) at end of year	2016-09-15	$0
Assets. Loans (other than to participants) at beginning of year	2016-09-15	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2016-09-15	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2016-09-15	$0
Other income not declared elsewhere	2016-09-15	$-9,780
Administrative expenses (other) incurred	2016-09-15	$39,608
Liabilities. Value of operating payables at end of year	2016-09-15	$0
Liabilities. Value of operating payables at beginning of year	2016-09-15	$0
Total non interest bearing cash at end of year	2016-09-15	$0
Total non interest bearing cash at beginning of year	2016-09-15	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-09-15	No
Income. Non cash contributions	2016-09-15	$0
Value of net income/loss	2016-09-15	$-2,865,750
Value of net assets at end of year (total assets less liabilities)	2016-09-15	$0
Value of net assets at beginning of year (total assets less liabilities)	2016-09-15	$28,989,611
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-09-15	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-09-15	No
Were any leases to which the plan was party in default or uncollectible	2016-09-15	No
Assets. partnership/joint venture interests at end of year	2016-09-15	$0
Assets. partnership/joint venture interests at beginning of year	2016-09-15	$0
Investment advisory and management fees	2016-09-15	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-09-15	$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-09-15	$21,101,264
Value of interest in pooled separate accounts at end of year	2016-09-15	$0
Value of interest in pooled separate accounts at beginning of year	2016-09-15	$0
Interest on participant loans	2016-09-15	$6,829
Income. Interest from loans (other than to participants)	2016-09-15	$0
Interest earned on other investments	2016-09-15	$0
Income. Interest from US Government securities	2016-09-15	$0
Income. Interest from corporate debt instruments	2016-09-15	$0
Value of interest in master investment trust accounts at end of year	2016-09-15	$0
Value of interest in master investment trust accounts at beginning of year	2016-09-15	$0
Value of interest in common/collective trusts at end of year	2016-09-15	$0
Value of interest in common/collective trusts at beginning of year	2016-09-15	$4,398,375
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2016-09-15	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2016-09-15	$1,311,602
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2016-09-15	$1,311,602
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2016-09-15	$0
Assets. Value of investments in 103.12 investment entities at end of year	2016-09-15	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2016-09-15	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2016-09-15	$0
Asset value of US Government securities at end of year	2016-09-15	$0
Asset value of US Government securities at beginning of year	2016-09-15	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-09-15	$711,920
Net investment gain/loss from pooled separate accounts	2016-09-15	$0
Net investment gain or loss from common/collective trusts	2016-09-15	$311,406
Net gain/loss from 103.12 investment entities	2016-09-15	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-09-15	No
Was there a failure to transmit to the plan any participant contributions	2016-09-15	No
Has the plan failed to provide any benefit when due under the plan	2016-09-15	No
Assets. Invements in employer securities at end of year	2016-09-15	$0
Assets. Invements in employer securities at beginning of year	2016-09-15	$0
Assets. Value of employer real property at end of year	2016-09-15	$0
Assets. Value of employer real property at beginning of year	2016-09-15	$0
Contributions received in cash from employer	2016-09-15	$0
Employer contributions (assets) at end of year	2016-09-15	$0
Employer contributions (assets) at beginning of year	2016-09-15	$915,391
Income. Dividends from preferred stock	2016-09-15	$0
Income. Dividends from common stock	2016-09-15	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-09-15	$4,986,037
Asset. Corporate debt instrument preferred debt at end of year	2016-09-15	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2016-09-15	$0
Asset. Corporate debt instrument debt (other) at end of year	2016-09-15	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2016-09-15	$0
Contract administrator fees	2016-09-15	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2016-09-15	No
Assets. Corporate common stocks other than exployer securities at end of year	2016-09-15	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2016-09-15	$0
Liabilities. Value of benefit claims payable at end of year	2016-09-15	$0
Liabilities. Value of benefit claims payable at beginning of year	2016-09-15	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2016-09-15	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2016-09-15	$0
Did the plan have assets held for investment	2016-09-15	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-09-15	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-09-15	Yes
Aggregate proceeds on sale of assets	2016-09-15	$0
Aggregate carrying amount (costs) on sale of assets	2016-09-15	$0
Liabilities. Value of acquisition indebtedness at end of year	2016-09-15	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2016-09-15	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-09-15	Yes
Opinion of an independent qualified public accountant for this plan	2016-09-15	Disclaimer
Accountancy firm name	2016-09-15	MELTON & MELTON LLP
Accountancy firm EIN	2016-09-15	741550819
2015 : NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2015 401k financial data
Unrealized appreciation/depreciation of real estate assets	2015-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2015-12-31	$0
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total transfer of assets to this plan	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Expenses. Interest paid	2015-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$2,417,417
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$965,073
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$912,925
Expenses. Certain deemed distributions of participant loans	2015-12-31	$0
Value of total corrective distributions	2015-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$2,227,082
Value of total assets at end of year	2015-12-31	$28,989,611
Value of total assets at beginning of year	2015-12-31	$27,537,267
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$52,148
Total income from rents	2015-12-31	$0
Total interest from all sources	2015-12-31	$11,331
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$995,091
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$995,091
Assets. Real estate other than employer real property at end of year	2015-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2015-12-31	$0
Administrative expenses professional fees incurred	2015-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2015-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2015-12-31	$0
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$500,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$1,311,691
Participant contributions at end of year	2015-12-31	$200,975
Participant contributions at beginning of year	2015-12-31	$209,352
Participant contributions at end of year	2015-12-31	$42,306
Participant contributions at beginning of year	2015-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2015-12-31	$1,019,698
Assets. Other investments not covered elsewhere at beginning of year	2015-12-31	$867,857
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$0
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2015-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2015-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2015-12-31	$0
Assets. Loans (other than to participants) at end of year	2015-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2015-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2015-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2015-12-31	$0
Other income not declared elsewhere	2015-12-31	$-31,508
Administrative expenses (other) incurred	2015-12-31	$52,148
Liabilities. Value of operating payables at end of year	2015-12-31	$0
Liabilities. Value of operating payables at beginning of year	2015-12-31	$0
Total non interest bearing cash at end of year	2015-12-31	$0
Total non interest bearing cash at beginning of year	2015-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Income. Non cash contributions	2015-12-31	$0
Value of net income/loss	2015-12-31	$1,452,344
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$28,989,611
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$27,537,267
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Assets. partnership/joint venture interests at end of year	2015-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2015-12-31	$0
Investment advisory and management fees	2015-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$21,101,264
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$20,224,596
Value of interest in pooled separate accounts at end of year	2015-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2015-12-31	$0
Interest on participant loans	2015-12-31	$9,890
Income. Interest from loans (other than to participants)	2015-12-31	$0
Interest earned on other investments	2015-12-31	$0
Income. Interest from US Government securities	2015-12-31	$0
Income. Interest from corporate debt instruments	2015-12-31	$0
Value of interest in master investment trust accounts at end of year	2015-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2015-12-31	$0
Value of interest in common/collective trusts at end of year	2015-12-31	$4,398,375
Value of interest in common/collective trusts at beginning of year	2015-12-31	$4,229,738
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2015-12-31	$1,311,602
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2015-12-31	$1,408,824
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2015-12-31	$1,408,824
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2015-12-31	$1,441
Assets. Value of investments in 103.12 investment entities at end of year	2015-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2015-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2015-12-31	$0
Asset value of US Government securities at end of year	2015-12-31	$0
Asset value of US Government securities at beginning of year	2015-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-770,324
Net investment gain/loss from pooled separate accounts	2015-12-31	$0
Net investment gain or loss from common/collective trusts	2015-12-31	$-14,255
Net gain/loss from 103.12 investment entities	2015-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Assets. Invements in employer securities at end of year	2015-12-31	$0
Assets. Invements in employer securities at beginning of year	2015-12-31	$0
Assets. Value of employer real property at end of year	2015-12-31	$0
Assets. Value of employer real property at beginning of year	2015-12-31	$0
Contributions received in cash from employer	2015-12-31	$915,391
Employer contributions (assets) at end of year	2015-12-31	$915,391
Employer contributions (assets) at beginning of year	2015-12-31	$596,900
Income. Dividends from preferred stock	2015-12-31	$0
Income. Dividends from common stock	2015-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$912,925
Asset. Corporate debt instrument preferred debt at end of year	2015-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2015-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2015-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2015-12-31	$0
Contract administrator fees	2015-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2015-12-31	No
Assets. Corporate common stocks other than exployer securities at end of year	2015-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2015-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2015-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2015-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2015-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2015-12-31	$0
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Aggregate proceeds on sale of assets	2015-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2015-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2015-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2015-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	MELTON & MELTON LLP
Accountancy firm EIN	2015-12-31	741550819
2014 : NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2014 401k financial data
Unrealized appreciation/depreciation of real estate assets	2014-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2014-12-31	$0
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total transfer of assets to this plan	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Expenses. Interest paid	2014-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$3,551,662
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$3,195,109
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$3,152,421
Expenses. Certain deemed distributions of participant loans	2014-12-31	$0
Value of total corrective distributions	2014-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$1,955,376
Value of total assets at end of year	2014-12-31	$27,537,267
Value of total assets at beginning of year	2014-12-31	$27,180,714
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$42,688
Total income from rents	2014-12-31	$0
Total interest from all sources	2014-12-31	$8,820
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$900,169
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$900,169
Assets. Real estate other than employer real property at end of year	2014-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2014-12-31	$0
Administrative expenses professional fees incurred	2014-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2014-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2014-12-31	$0
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$500,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$1,249,259
Participant contributions at end of year	2014-12-31	$209,352
Participant contributions at beginning of year	2014-12-31	$137,375
Participant contributions at end of year	2014-12-31	$0
Participant contributions at beginning of year	2014-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2014-12-31	$867,857
Assets. Other investments not covered elsewhere at beginning of year	2014-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$109,217
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2014-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2014-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2014-12-31	$0
Assets. Loans (other than to participants) at end of year	2014-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2014-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2014-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2014-12-31	$0
Other income not declared elsewhere	2014-12-31	$40,712
Administrative expenses (other) incurred	2014-12-31	$42,688
Liabilities. Value of operating payables at end of year	2014-12-31	$0
Liabilities. Value of operating payables at beginning of year	2014-12-31	$0
Total non interest bearing cash at end of year	2014-12-31	$0
Total non interest bearing cash at beginning of year	2014-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Income. Non cash contributions	2014-12-31	$0
Value of net income/loss	2014-12-31	$356,553
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$27,537,267
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$27,180,714
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Assets. partnership/joint venture interests at end of year	2014-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2014-12-31	$0
Investment advisory and management fees	2014-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$20,224,596
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$24,699,509
Value of interest in pooled separate accounts at end of year	2014-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$0
Interest on participant loans	2014-12-31	$9,421
Income. Interest from loans (other than to participants)	2014-12-31	$0
Interest earned on other investments	2014-12-31	$0
Income. Interest from US Government securities	2014-12-31	$0
Income. Interest from corporate debt instruments	2014-12-31	$0
Value of interest in master investment trust accounts at end of year	2014-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2014-12-31	$0
Value of interest in common/collective trusts at end of year	2014-12-31	$4,229,738
Value of interest in common/collective trusts at beginning of year	2014-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2014-12-31	$1,408,824
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2014-12-31	$1,452,411
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2014-12-31	$1,452,411
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2014-12-31	$-601
Assets. Value of investments in 103.12 investment entities at end of year	2014-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2014-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2014-12-31	$0
Asset value of US Government securities at end of year	2014-12-31	$0
Asset value of US Government securities at beginning of year	2014-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$469,119
Net investment gain/loss from pooled separate accounts	2014-12-31	$0
Net investment gain or loss from common/collective trusts	2014-12-31	$177,466
Net gain/loss from 103.12 investment entities	2014-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Assets. Invements in employer securities at end of year	2014-12-31	$0
Assets. Invements in employer securities at beginning of year	2014-12-31	$0
Assets. Value of employer real property at end of year	2014-12-31	$0
Assets. Value of employer real property at beginning of year	2014-12-31	$0
Contributions received in cash from employer	2014-12-31	$596,900
Employer contributions (assets) at end of year	2014-12-31	$596,900
Employer contributions (assets) at beginning of year	2014-12-31	$891,419
Income. Dividends from preferred stock	2014-12-31	$0
Income. Dividends from common stock	2014-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$3,152,421
Asset. Corporate debt instrument preferred debt at end of year	2014-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2014-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2014-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2014-12-31	$0
Contract administrator fees	2014-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2014-12-31	No
Assets. Corporate common stocks other than exployer securities at end of year	2014-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2014-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2014-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2014-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2014-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2014-12-31	$0
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Aggregate proceeds on sale of assets	2014-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2014-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2014-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2014-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	MELTON & MELTON LLP
Accountancy firm EIN	2014-12-31	741550819
2013 : NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2013 401k financial data
Unrealized appreciation/depreciation of real estate assets	2013-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2013-12-31	$0
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total transfer of assets to this plan	2013-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Expenses. Interest paid	2013-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$6,895,835
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$4,096,114
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$4,066,955
Expenses. Certain deemed distributions of participant loans	2013-12-31	$0
Value of total corrective distributions	2013-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$2,141,857
Value of total assets at end of year	2013-12-31	$27,180,714
Value of total assets at beginning of year	2013-12-31	$24,380,993
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$29,159
Total income from rents	2013-12-31	$0
Total interest from all sources	2013-12-31	$10,522
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$1,093,877
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$1,093,877
Assets. Real estate other than employer real property at end of year	2013-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2013-12-31	$0
Administrative expenses professional fees incurred	2013-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2013-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2013-12-31	$0
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$500,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$1,213,714
Participant contributions at end of year	2013-12-31	$137,375
Participant contributions at beginning of year	2013-12-31	$133,995
Participant contributions at end of year	2013-12-31	$0
Participant contributions at beginning of year	2013-12-31	$29,290
Assets. Other investments not covered elsewhere at end of year	2013-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2013-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$36,724
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2013-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2013-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2013-12-31	$0
Assets. Loans (other than to participants) at end of year	2013-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2013-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2013-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2013-12-31	$0
Other income not declared elsewhere	2013-12-31	$0
Administrative expenses (other) incurred	2013-12-31	$29,159
Liabilities. Value of operating payables at end of year	2013-12-31	$0
Liabilities. Value of operating payables at beginning of year	2013-12-31	$0
Total non interest bearing cash at end of year	2013-12-31	$0
Total non interest bearing cash at beginning of year	2013-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Income. Non cash contributions	2013-12-31	$0
Value of net income/loss	2013-12-31	$2,799,721
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$27,180,714
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$24,380,993
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Assets. partnership/joint venture interests at end of year	2013-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2013-12-31	$0
Investment advisory and management fees	2013-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$24,699,509
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$21,659,844
Value of interest in pooled separate accounts at end of year	2013-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2013-12-31	$0
Interest on participant loans	2013-12-31	$10,278
Income. Interest from loans (other than to participants)	2013-12-31	$0
Interest earned on other investments	2013-12-31	$0
Income. Interest from US Government securities	2013-12-31	$0
Income. Interest from corporate debt instruments	2013-12-31	$0
Value of interest in master investment trust accounts at end of year	2013-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2013-12-31	$0
Value of interest in common/collective trusts at end of year	2013-12-31	$0
Value of interest in common/collective trusts at beginning of year	2013-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2013-12-31	$1,452,411
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2013-12-31	$1,614,658
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2013-12-31	$1,614,658
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2013-12-31	$244
Assets. Value of investments in 103.12 investment entities at end of year	2013-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2013-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2013-12-31	$0
Asset value of US Government securities at end of year	2013-12-31	$0
Asset value of US Government securities at beginning of year	2013-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$3,649,579
Net investment gain/loss from pooled separate accounts	2013-12-31	$0
Net investment gain or loss from common/collective trusts	2013-12-31	$0
Net gain/loss from 103.12 investment entities	2013-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Assets. Invements in employer securities at end of year	2013-12-31	$0
Assets. Invements in employer securities at beginning of year	2013-12-31	$0
Assets. Value of employer real property at end of year	2013-12-31	$0
Assets. Value of employer real property at beginning of year	2013-12-31	$0
Contributions received in cash from employer	2013-12-31	$891,419
Employer contributions (assets) at end of year	2013-12-31	$891,419
Employer contributions (assets) at beginning of year	2013-12-31	$943,206
Income. Dividends from preferred stock	2013-12-31	$0
Income. Dividends from common stock	2013-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$4,066,955
Asset. Corporate debt instrument preferred debt at end of year	2013-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2013-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2013-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2013-12-31	$0
Contract administrator fees	2013-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2013-12-31	No
Assets. Corporate common stocks other than exployer securities at end of year	2013-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2013-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2013-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2013-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2013-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2013-12-31	$0
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Aggregate proceeds on sale of assets	2013-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2013-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2013-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2013-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	MELTON & MELTON LLP
Accountancy firm EIN	2013-12-31	741550819
2012 : NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2012 401k financial data
Total income from all sources (including contributions)	2012-12-31	$4,771,923
Total of all expenses incurred	2012-12-31	$2,545,374
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$2,532,444
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$2,121,622
Value of total assets at end of year	2012-12-31	$24,380,993
Value of total assets at beginning of year	2012-12-31	$22,154,444
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$12,930
Total interest from all sources	2012-12-31	$13,057
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$621,690
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2012-12-31	$621,690
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$500,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$1,178,416
Participant contributions at end of year	2012-12-31	$133,995
Participant contributions at beginning of year	2012-12-31	$140,397
Participant contributions at end of year	2012-12-31	$29,290
Participant contributions at beginning of year	2012-12-31	$23,261
Administrative expenses (other) incurred	2012-12-31	$12,930
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$2,226,549
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$24,380,993
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$22,154,444
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$21,659,844
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$19,090,836
Interest on participant loans	2012-12-31	$12,872
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2012-12-31	$1,614,658
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2012-12-31	$1,996,289
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2012-12-31	$1,996,289
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2012-12-31	$185
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$2,015,554
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$943,206
Employer contributions (assets) at end of year	2012-12-31	$943,206
Employer contributions (assets) at beginning of year	2012-12-31	$903,661
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$2,532,444
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2012-12-31	No
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	MELTON & MELTON LLP
Accountancy firm EIN	2012-12-31	741550819
2011 : NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2011 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$0
Total income from all sources (including contributions)	2011-12-31	$1,617,212
Total of all expenses incurred	2011-12-31	$2,234,746
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$2,225,827
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$2,108,645
Value of total assets at end of year	2011-12-31	$22,154,444
Value of total assets at beginning of year	2011-12-31	$22,771,978
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-12-31	$8,919
Total interest from all sources	2011-12-31	$12,849
Total dividends received (eg from common stock, registered investment company shares)	2011-12-31	$576,397
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2011-12-31	$576,397
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$500,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2011-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$1,204,984
Participant contributions at end of year	2011-12-31	$140,397
Participant contributions at beginning of year	2011-12-31	$96,154
Participant contributions at end of year	2011-12-31	$23,261
Participant contributions at beginning of year	2011-12-31	$28,828
Administrative expenses (other) incurred	2011-12-31	$8,919
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$-617,534
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$22,154,444
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$22,771,978
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-12-31	$19,090,836
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-12-31	$20,520,982
Interest on participant loans	2011-12-31	$12,278
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2011-12-31	$1,996,289
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2011-12-31	$1,215,129
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2011-12-31	$1,215,129
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2011-12-31	$571
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-1,080,679
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Contributions received in cash from employer	2011-12-31	$903,661
Employer contributions (assets) at end of year	2011-12-31	$903,661
Employer contributions (assets) at beginning of year	2011-12-31	$910,885
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$2,225,827
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2011-12-31	No
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Qualified
Accountancy firm name	2011-12-31	MELTON & MELTON
Accountancy firm EIN	2011-12-31	741550819
2010 : NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2010 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total income from all sources (including contributions)	2010-12-31	$4,338,570
Total of all expenses incurred	2010-12-31	$1,213,347
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$1,204,809
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$2,176,735
Value of total assets at end of year	2010-12-31	$22,771,978
Value of total assets at beginning of year	2010-12-31	$19,646,755
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$8,538
Total interest from all sources	2010-12-31	$8,438
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$505,912
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2010-12-31	$505,912
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$500,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2010-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$1,229,319
Participant contributions at end of year	2010-12-31	$96,154
Participant contributions at beginning of year	2010-12-31	$85,203
Participant contributions at end of year	2010-12-31	$28,828
Participant contributions at beginning of year	2010-12-31	$24,747
Income. Received or receivable in cash from other sources (including rollovers)	2010-12-31	$36,517
Administrative expenses (other) incurred	2010-12-31	$8,538
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$3,125,223
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$22,771,978
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$19,646,755
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$20,520,982
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$16,545,027
Interest on participant loans	2010-12-31	$7,697
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2010-12-31	$1,215,129
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2010-12-31	$1,493,078
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2010-12-31	$1,493,078
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2010-12-31	$741
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$1,647,485
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$910,899
Employer contributions (assets) at end of year	2010-12-31	$910,885
Employer contributions (assets) at beginning of year	2010-12-31	$1,498,700
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$1,204,809
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2010-12-31	No
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	MELTON AND MELTON LLP
Accountancy firm EIN	2010-12-31	741550819
2009 : NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN

2016: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	Yes
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	Yes
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2010: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2010 form 5500 responses
2010-01-01	Type of plan entity	Single employer plan
2010-01-01	Submission has been amended	No
2010-01-01	This submission is the final filing	No
2010-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2010-01-01	Plan funding arrangement – Trust	Yes
2010-01-01	Plan benefit arrangement - Trust	Yes
2009: NEW YORK ONCOLOGY HEMATOLOGY, P.C. 401(K) PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	NEW YORK ONCOLOGY HEMATOLOGY P.C.
Employer identification number (EIN):	141799724
NAIC Classification:	621111
NAIC Description:	Offices of Physicians (except Mental Health Specialists)

Jurisdiction of Incorporation:	New York Department of State
Incorporation Date:	1997-11-07
Company Identification Number:	2197278
Legal Registered Office Address:	400 PATROON CREEK BLVD STE 1 ALBANY United States of America (USA) 12206